Purchase Order 75N95023P00663

Award Date 9/13/23
Potential Completion Date 12/14/23
Potential Value $132K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Becton, Dickinson & Co
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $776,765.60 firm fixed price purchase order contract to Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division for the purchase of one BD Biosciences FACSDISCOVER 8S Cell Sorter instrument. Performance will take place in San Jose, California over a period of approximately two months from September 2023 through November 2023. BD Biosciences...
This contract is a firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) to Becton, Dickinson and Company (BD), a global medical technology manufacturer. The purpose is to provide a maintenance and service agreement for BD's custom FACSYMPHONY A5 flow cytometer used by NINDS's Viral Immunology and Intravital Imaging Section. The contract has a potential value of...
The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $343,802.50 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for a FACSymphony A3 Flow Cytometry Analyzer with High Throughput Sampler. The contract runs from September 18, 2020 to January 30, 2021 with performance in San Jose, California. This purchase order fulfills the original...
Becton, Dickinson and Company (BD Biosciences division) has been awarded a firm fixed price purchase order totaling $17,668.80 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for annual service of BD Biosciences' FACSCelesta flow cytometry system located in San Jose, California, with performance through March 1, 2025. No set-aside designation was used for this procurement. BD Biosciences will provide maintenance and support for the...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $834,695.07 purchase order contract to Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division for the delivery of a FACSDISCOVER S8 CELL SORTER. The prime contractor, Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division, will provide the cell sorting instrument from its parent company Becton, Dickinson And Company's BD Biosciences division....
This is a $600,264.33 firm-fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Becton, Dickinson and Company (BD), a manufacturer of medical devices, instruments, reagents, and related products. The contract is for the delivery of a BD FACSymphony A-5 30-color flow cytometer, a specialized laboratory instrument used for advanced cellular analysis. BD, through its IDS division operating...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Becton, Dickinson And Company (BD), a global medical technology manufacturer, for a service agreement to provide a Facsaria Fusion SORP flow cytometry system with Rhapsody and OBIS laser accessories. The award has a potential value of $163,080.00 and a completion date of January 4, 2024. This purchase order is not set aside...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD) to acquire a BD FACSymphony A3 flow cytometer analyzer, a five-laser, 23-color system. The contract, which did not have a set-aside designation, was awarded on September 20, 2019 with a completion date of January 20, 2020 and a potential value of $359,443.75. BD Biosciences, a division of BD focused on...
This is a $764,203.60 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Becton, Dickinson & Co (BD), a large medical technology manufacturer. The contract is for a Becton Dickinson FACSymphony S6 cell sorter, which is a specialized flow cytometry instrument used for advanced medical research and clinical laboratory applications. The contract has a completion date of September 29, 2025. There is no...
The Department of Health and Human Services National Institutes of Health awarded a firm-fixed-price delivery order to Becton, Dickinson and Company (BD) for a maintenance agreement on a Facsaria Fusion 4 laser system. The contract has a potential value of $135,576.00 and a completion date of December 5, 2022. BD is a global medical technology company that supplies specialized equipment, reagents, and services to support biomedical research and clinical applications, including under various...

The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a firm-fixed-price purchase order contract valued at $132,482.63 to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for the procurement of a BD FACSCelesta flow cytometer analyzer system. The solicitation requested a BD FACSCelesta system or equivalent for cell sorting and analysis to support ongoing research within the Neurosurgical Oncology Unit. Under the contract, BD Biosciences will deliver the system to the specified location in San Jose, California, install it, provide training on its use, and warranty services. The period of performance is from September 13, 2023 through December 14, 2023. No subcontractors or set aside designations were identified.

Generated 12/24/23, 2:04 AM